The gut microbiota plays an important role in cardio-metabolic diseases with diet being
among the strongest modulators of gut microbiota composition and function. Resistant …

Abstract Purpose of this Review This review assesses the latest evidence linking short-chain
fatty acids (SCFA) with host metabolic health and cardiovascular disease (CVD) risk and …

Cardiometabolic disease (CMD), such as type 2 diabetes mellitus and cardiovascular
disease, contributes significantly to morbidity and mortality on a global scale. The gut …

The connection between the gut microbiota and the aetiology of obesity and cardiometabolic
disorders is increasingly being recognized by clinicians. Our gut microbiota might affect the …

Gut microbiota encompasses a wide variety of commensal microorganisms consisting of
trillions of bacteria, fungi, and viruses. This microbial population coexists in symbiosis with …

Gut microbiota have recently been suggested to play a part in low-grade systemic
inflammation, which is considered a key risk factor for cardiometabolic disorders. Diet is …

The human gut harbors microbial ecology that is in a symbiotic relationship with its host and
has a vital function in keeping host homeostasis. Inimical alterations in the composition of …

Fiber fermentation by gut microbiota yields short-chain fatty acids (SCFAs) that are either
absorbed by the gut or excreted in feces. Studies are conflicting as to whether SCFAs are …

The intestine is colonized by a considerable community of microorganisms that cohabits
within the host and plays a critical role in maintaining host homeostasis. Recently …

Despite major strides in reducing cardiovascular disease (CVD) burden with modification of
classic CVD risk factors, significant residual risks remain. Recent discoveries that linked …